West Pharmaceutical Services (WST) Revenue & Revenue Breakdown
West Pharmaceutical Services Revenue Highlights
Latest Revenue (Y)
$2.95B
Latest Revenue (Q)
$702.00M
Main Segment (Y)
Proprietary Products
Main Geography (Y)
UNITED STATES
West Pharmaceutical Services Revenue by Period
West Pharmaceutical Services Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.95B | 2.18% |
| 2022-12-31 | $2.89B | 1.95% |
| 2021-12-31 | $2.83B | 31.89% |
| 2020-12-31 | $2.15B | 16.69% |
| 2019-12-31 | $1.84B | 7.13% |
| 2018-12-31 | $1.72B | 7.40% |
| 2017-12-31 | $1.60B | 5.96% |
| 2016-12-31 | $1.51B | 7.81% |
| 2015-12-31 | $1.40B | -1.52% |
| 2014-12-31 | $1.42B | 3.87% |
| 2013-12-31 | $1.37B | 8.05% |
| 2012-12-31 | $1.27B | 6.21% |
| 2011-12-31 | $1.19B | 7.93% |
| 2010-12-31 | $1.10B | 4.64% |
| 2009-12-31 | $1.06B | 0.44% |
| 2008-12-31 | $1.05B | 3.04% |
| 2007-12-31 | $1.02B | 11.69% |
| 2006-12-31 | $913.30M | 30.53% |
| 2005-12-31 | $699.70M | 29.19% |
| 2004-12-31 | $541.60M | 10.37% |
| 2003-12-31 | $490.70M | 16.92% |
| 2002-12-31 | $419.70M | 5.74% |
| 2001-12-31 | $396.90M | -7.72% |
| 2000-12-31 | $430.10M | -8.31% |
| 1999-12-31 | $469.10M | 4.31% |
| 1998-12-31 | $449.70M | -0.62% |
| 1997-12-31 | $452.50M | -1.37% |
| 1996-12-31 | $458.80M | 11.12% |
| 1995-12-31 | $412.90M | 13.09% |
| 1994-12-31 | $365.10M | 4.70% |
| 1993-12-31 | $348.70M | - |
West Pharmaceutical Services generated $2.95B in revenue during NA 2023, up 2.18% compared to the previous quarter, and up 171.76% compared to the same period a year ago.
West Pharmaceutical Services Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $702.00M | 0.95% |
| 2024-03-31 | $695.40M | -5.00% |
| 2023-12-31 | $732.00M | -2.06% |
| 2023-09-30 | $747.40M | -0.85% |
| 2023-06-30 | $753.80M | 5.19% |
| 2023-03-31 | $716.60M | 1.11% |
| 2022-12-31 | $708.70M | 3.17% |
| 2022-09-30 | $686.90M | -10.94% |
| 2022-06-30 | $771.30M | 7.13% |
| 2022-03-31 | $720.00M | -1.48% |
| 2021-12-31 | $730.80M | 3.44% |
| 2021-09-30 | $706.50M | -2.36% |
| 2021-06-30 | $723.60M | 7.89% |
| 2021-03-31 | $670.70M | 15.60% |
| 2020-12-31 | $580.20M | 5.88% |
| 2020-09-30 | $548.00M | 3.95% |
| 2020-06-30 | $527.20M | 7.26% |
| 2020-03-31 | $491.50M | 4.44% |
| 2019-12-31 | $470.60M | 3.18% |
| 2019-09-30 | $456.10M | -2.90% |
| 2019-06-30 | $469.70M | 5.91% |
| 2019-03-31 | $443.50M | 4.97% |
| 2018-12-31 | $422.50M | -2.13% |
| 2018-09-30 | $431.70M | -3.53% |
| 2018-06-30 | $447.50M | 7.65% |
| 2018-03-31 | $415.70M | 0.02% |
| 2017-12-31 | $415.60M | 4.37% |
| 2017-09-30 | $398.20M | 0.15% |
| 2017-06-30 | $397.60M | 2.55% |
| 2017-03-31 | $387.70M | 1.41% |
| 2016-12-31 | $382.30M | 1.49% |
| 2016-09-30 | $376.70M | -2.91% |
| 2016-06-30 | $388.00M | 7.15% |
| 2016-03-31 | $362.10M | 0.67% |
| 2015-12-31 | $359.70M | 4.41% |
| 2015-09-30 | $344.50M | -4.23% |
| 2015-06-30 | $359.70M | 7.09% |
| 2015-03-31 | $335.90M | -3.97% |
| 2014-12-31 | $349.80M | -1.71% |
| 2014-09-30 | $355.90M | -3.52% |
| 2014-06-30 | $368.90M | 6.37% |
| 2014-03-31 | $346.80M | 1.20% |
| 2013-12-31 | $342.70M | 0.26% |
| 2013-09-30 | $341.80M | -0.78% |
| 2013-06-30 | $344.50M | 1.50% |
| 2013-03-31 | $339.40M | 5.57% |
| 2012-12-31 | $321.50M | 5.83% |
| 2012-09-30 | $303.80M | -6.47% |
| 2012-06-30 | $324.80M | 2.69% |
| 2012-03-31 | $316.30M | 7.08% |
| 2011-12-31 | $295.40M | 0.61% |
| 2011-09-30 | $293.60M | -4.64% |
| 2011-06-30 | $307.90M | 4.23% |
| 2011-03-31 | $295.40M | 6.72% |
| 2010-12-31 | $276.80M | 1.99% |
| 2010-09-30 | $271.40M | -3.69% |
| 2010-06-30 | $281.80M | 2.58% |
| 2010-03-31 | $274.70M | -6.37% |
| 2009-12-31 | $293.40M | 13.33% |
| 2009-09-30 | $258.90M | -0.80% |
| 2009-06-30 | $261.00M | 7.67% |
| 2009-03-31 | $242.40M | -0.98% |
| 2008-12-31 | $244.80M | -4.45% |
| 2008-09-30 | $256.20M | -8.27% |
| 2008-06-30 | $279.30M | 3.18% |
| 2008-03-31 | $270.70M | 5.70% |
| 2007-12-31 | $256.10M | - |
West Pharmaceutical Services generated $702.00M in revenue during Q2 2024, up 0.95% compared to the previous quarter, and up 97.96% compared to the same period a year ago.
West Pharmaceutical Services Revenue Breakdown
West Pharmaceutical Services Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Proprietary Products | $2.40B | $2.41B | $2.32B | $1.65B | $1.40B |
| Contract Manufactured Products | $552.50M | $480.40M | $514.70M | $498.60M | $441.50M |
| Corporate and Eliminations | - | - | - | - | $-200.00K |
West Pharmaceutical Services's latest annual revenue breakdown by segment (product or service), as of Dec 23: Proprietary Products (81.27%), and Contract Manufactured Products (18.73%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Contract Manufactured Products | $142.40M | $135.90M | $419.00M | $133.50M | $118.70M | $127.10M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Proprietary Products | - | - | $1.81B | $583.10M | $601.30M | $543.70M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Delivery Systems | - | - | - | $144.90M | $135.80M | $120.00M | $117.80M | $129.70M | $136.40M | $126.60M | $127.80M | $118.10M | $111.10M | $109.40M | $103.10M | $106.70M | $101.50M | - | - | - |
| Packaging Systems | - | - | - | $602.50M | $567.00M | $653.70M | $577.00M | $587.30M | $421.50M | $399.50M | $373.50M | $345.20M | $360.30M | $340.40M | $325.20M | $346.00M | - | - | - | - |
| Intersegment Eliminations | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-100.00K | $-200.00K | $-200.00K | - | - | - |
West Pharmaceutical Services's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Contract Manufactured Products (100.00%).
West Pharmaceutical Services Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| FRANCE | $282.90M | $237.90M | $213.00M | $172.70M | $150.60M |
| UNITED STATES | $1.24B | $1.29B | $1.20B | $975.60M | $814.70M |
| Other Europe Countries | $388.10M | $359.20M | $341.30M | $236.80M | $251.10M |
| Other Countries | $348.50M | $364.30M | $357.40M | $253.70M | $213.40M |
| IRELAND | $285.70M | $240.30M | $247.60M | $226.00M | $173.80M |
| GERMANY | $406.10M | $398.70M | $474.30M | $282.10M | $236.30M |
West Pharmaceutical Services's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (41.99%), GERMANY (13.77%), Other Europe Countries (13.16%), Other Countries (11.81%), IRELAND (9.69%), and FRANCE (9.59%).
West Pharmaceutical Services Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BDX | Becton, Dickinson and | $19.37B | $4.99B |
| BAX | Baxter | $14.81B | $3.59B |
| ALC | Alcon | $10.09B | $2.46B |
| RMD | ResMed | $4.69B | $1.20B |
| HOLX | Hologic | $4.03B | $1.01B |
| COO | Cooper Companies | $3.59B | $1.00B |
| TFX | Teleflex | $2.97B | $749.69M |
| WST | West Pharmaceutical Services | $2.95B | $702.00M |
| ICUI | ICU Medical | $2.26B | $596.46M |
| HAE | Haemonetics | $1.31B | $336.17M |
| MMSI | Merit Medical Systems | $1.26B | $338.00M |
| EMBC | Embecta | $1.12B | $272.50M |
| RGEN | Repligen | $638.76M | $154.07M |
WST Revenue FAQ
What is West Pharmaceutical Services’s yearly revenue?
West Pharmaceutical Services's yearly revenue for 2023 was $2.95B, representing an increase of 2.18% compared to 2022. The company's yearly revenue for 2022 was $2.89B, representing an increase of 1.95% compared to 2021. WST's yearly revenue for 2021 was $2.83B, representing an increase of 31.89% compared to 2020.
What is West Pharmaceutical Services’s quarterly revenue?
West Pharmaceutical Services's quarterly revenue for Q2 2024 was $702M, a 0.95% increase from the previous quarter (Q1 2024), and a -6.87% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $695.4M, a -5.00% decrease from the previous quarter (Q4 2023), and a -2.96% decrease year-over-year (Q1 2023). WST's quarterly revenue for Q4 2023 was $732M, a -2.06% decrease from the previous quarter (Q3 2023), and a 3.29% increase year-over-year (Q4 2022).
What is West Pharmaceutical Services’s revenue growth rate?
West Pharmaceutical Services's revenue growth rate for the last 3 years (2021-2023) was 4.17%, and for the last 5 years (2019-2023) was 60.32%.
What are West Pharmaceutical Services’s revenue streams?
West Pharmaceutical Services's revenue streams in c 23 are Proprietary Products, and Contract Manufactured Products. Proprietary Products generated $2.4B in revenue, accounting 81.27% of the company's total revenue, down -0.39% year-over-year. Contract Manufactured Products generated $552.5M in revenue, accounting 18.73% of the company's total revenue, up 15.01% year-over-year.
What is West Pharmaceutical Services’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of West Pharmaceutical Services was Proprietary Products. This segment made a revenue of $2.4B, representing 81.27% of the company's total revenue.